英文摘要 |
FDG-PET/CT is used to evaluate malignancies due to its biochemical characteristics. However, there is a possibility of false-positive results. Herein, we report two cases of false-positive thyroid lesions and discussed the limitations of FDG-PET/CT. The first case was a 54-year-old female, who presented an FDGavid mass in the left thyroid gland on whole-body PET/CT. Seven years later, neck sonography revealed another nodule in the right lobe of the thyroid. The two nodules progressively enlarged in size. FDG-PET/CT was performed again 12 years after the left nodule was first observed. Both nodules were FDG-avid, with even higher uptake. Since the pathological report of fine-needle aspiration (FNA) of the left nodule showed greater cellularity, the patient underwent left thyroid lobectomy and right excision. The final pathological report showed bilateral nodular goiters with a Ki-67 index <1%. The second case was that of a 67-year-old female; after surgical treatment of breast cancer and mediastinal squamous cell carcinoma, she was found to have diffuse F-18 2-Fluoro-2-deoxyglucose (FDG) uptake involving the bilateral thyroid glands during PET evaluation for cancer workup. Neck ultrasonography revealed the characteristics of Hashimoto’s disease. In these two cases, we reviewed the diagnostic role of FDG-PET/CT in thyroid lesions. Diffuse FDG uptake often indicates thyroiditis, while focal uptake has a high false-positive rate for detecting thyroid cancer. In conclusion, a multidimensional examination of thyroid lesions is important. |